Ellingrod Laboratory

Our research interests are primarily related to improving the safety of mental health pharmacotherapy through precision medicine research. We have been focusing on the role of pharmacogenetically regulated folate metabolism and its relationship to metabolic syndrome and endothelial dysfunction seen with antipsychotic use in patients with schizophrenia or bipolar disorder. Recent work has incorporated methylation, microbiome, and metabolomic data to further our understanding of the relationship between medication use and cardiovascular disease risk in these populations. We employ molecular biology techniques in our work.